Literature DB >> 21656825

Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.

Hisashi Shimojo1, Motohiro Kobayashi, Takayuki Kamigaito, Yasuyo Shimojo, Minoru Fukuda, Jun Nakayama.   

Abstract

BACKGROUND: α-Dystroglycan (DG) carries glycan chains that bind to laminin and thus function in homeostasis of not only skeletal muscle but also of various epithelial cells. Loss of glycosylation has been suggested to play important roles in tumor development, particularly in detachment and migration of carcinoma cells. We previously reported that glycosylation of α-DG, but not levels of α-DG core protein itself, is reduced in prostate carcinoma. In this study, we investigate the association between reduction of laminin-binding glycans on α-DG and the degree of tumor cell differentiation and/or infiltrative properties, as assessed by the Gleason grading system.
METHODS: Immunohistochemical analysis of 146 biopsy specimens of prostate adenocarcinoma with various Gleason scores was carried out employing IIH6 and 6C1 antibodies, which recognize laminin-binding glycans on α-DG and α-DG core proteins, respectively. Double immunofluorescence staining was performed to evaluate colocalization of α-DG and laminin, and to determine which types of epithelial cells express laminin-binding glycans on α-DG.
RESULTS: Reduction of α-DG glycosylation, rather than loss of α-DG core protein, was correlated with higher Gleason patterns. Reduction was most conspicuous at the interface between carcinoma cells and the basement membrane. In addition, in non-neoplastic prostate glands, laminin-binding glycans were expressed predominantly on the basolateral surface of basal cells.
CONCLUSIONS: Reduced expression of laminin-binding glycans on α-DG may contribute to formation of highly infiltrative behavior of prostate carcinoma cells. Substantial reduction of laminin-binding glycans in carcinoma tissue could be partly ascribed to disappearance of pre-existing basal cells.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656825      PMCID: PMC3174275          DOI: 10.1002/pros.21330

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  23 in total

Review 1.  Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made.

Authors:  J I Epstein
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

2.  A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells.

Authors:  John Muschler; Dinah Levy; Roseanne Boudreau; Michael Henry; Kevin Campbell; Mina J Bissell
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

3.  Molecular recognition by LARGE is essential for expression of functional dystroglycan.

Authors:  Motoi Kanagawa; Fumiaki Saito; Stefan Kunz; Takako Yoshida-Moriguchi; Rita Barresi; Yvonne M Kobayashi; John Muschler; Jan P Dumanski; Daniel E Michele; Michael B A Oldstone; Kevin P Campbell
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

4.  Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland.

Authors:  F P O'Malley; D J Grignon; D T Shum
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration.

Authors:  A P Verhagen; T W Aalders; F C Ramaekers; F M Debruyne; J A Schalken
Journal:  Prostate       Date:  1988       Impact factor: 4.104

6.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

7.  Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

Authors:  Alessandro Sgambato; Mario Migaldi; Micaela Montanari; Andrea Camerini; Andrea Brancaccio; Giulio Rossi; Rodolfo Cangiano; Carmen Losasso; Giovanni Capelli; Gian Paolo Trentini; Achille Cittadini
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

8.  Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells.

Authors:  Jarnail Singh; Yoko Itahana; Selena Knight-Krajewski; Motoi Kanagawa; Kevin P Campbell; Mina J Bissell; John Muschler
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

9.  Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.

Authors:  Xingfeng Bao; Motohiro Kobayashi; Shingo Hatakeyama; Kiyohiko Angata; Donald Gullberg; Jun Nakayama; Michiko N Fukuda; Minoru Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-08       Impact factor: 11.205

10.  Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity.

Authors:  Hiroshi Manya; Atsuro Chiba; Aruto Yoshida; Xiaohui Wang; Yasunori Chiba; Yoshifumi Jigami; Richard U Margolis; Tamao Endo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

View more
  8 in total

1.  The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.

Authors:  Qin Huang; Michael R Miller; James Schappet; Michael D Henry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Reduction of α-dystroglycan expression is correlated with poor prognosis in glioma.

Authors:  Xin Zhang; Xiang-Hui Dong; Yue Ma; Lan-Feng Li; He Wu; Min Zhou; Yun-He Gu; Guo-Zhong Li; De-Sheng Wang; Xiao-Feng Zhang; Jing Mou; Ji-Ping Qi
Journal:  Tumour Biol       Date:  2014-08-20

3.  Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.

Authors:  Duy T Tran; Jae-Min Lim; Mian Liu; Stephanie H Stalnaker; Lance Wells; Kelly G Ten Hagen; David Live
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

4.  Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Authors:  Alison K Esser; Michael R Miller; Qin Huang; Melissa M Meier; Daniel Beltran-Valero de Bernabé; Christopher S Stipp; Kevin P Campbell; Charles F Lynch; Brian J Smith; Michael B Cohen; Michael D Henry
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

5.  Fer kinase regulates cell migration through α-dystroglycan glycosylation.

Authors:  Tohru Yoneyama; Kiyohiko Angata; Xingfeng Bao; Sara Courtneidge; Sumit K Chanda; Minoru Fukuda
Journal:  Mol Biol Cell       Date:  2012-01-11       Impact factor: 4.138

6.  VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancer.

Authors:  Vassilis Aggelis; Rachel A Craven; Jianhe Peng; Patricia Harnden; Lana Schaffer; Gilberto E Hernandez; Steven R Head; Eamonn R Maher; Robert Tonge; Peter J Selby; Rosamonde E Banks
Journal:  Int J Oncol       Date:  2013-08-21       Impact factor: 5.650

7.  Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.

Authors:  Mary Luz Uribe; Carmen Haro; María Paz Ventero; Laura Campello; Jesús Cruces; José Martín-Nieto
Journal:  Mol Vis       Date:  2016-06-16       Impact factor: 2.367

8.  γ-Secretase Dependent Nuclear Targeting of Dystroglycan.

Authors:  Daniel Leocadio; Andrew Mitchell; Steve J Winder
Journal:  J Cell Biochem       Date:  2016-03-31       Impact factor: 4.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.